XML 45 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity (Tables)
6 Months Ended
Jun. 30, 2017
Equity [Abstract]  
Schedule of share repurchases
Share repurchases for the periods ended June 30 were as follows: 
(in millions, except average price)
Three Months
 
Six Months
 
2017
 
2016
 
2017
 
2016
Total number of shares purchased
1.1

 
1.4

 
2.6

 
3.5

Average price paid per share 1
$
137.49

 
$
107.74

 
$
133.01

 
$
98.05

Total cash utilized 1
$
145

 
$
147

 
$
346

 
$
347


1 
In December of 2015, 0.3 million shares were repurchased for approximately $26 million, which settled in January of 2016. Cash used for financing activities only reflects those shares which settled during the six months ended June 30, 2016 resulting in $373 million of cash used to repurchase shares.

Schedule of redeemable noncontrolling interest
Changes to redeemable noncontrolling interest during the six months ended June 30, 2017 were as follows:
(in millions)
 
Balance as of December 31, 2016
$
1,080

Net income attributable to noncontrolling interest
61

Distributions payable to noncontrolling interest
(36
)
Redemption value adjustment
2

Balance as of June 30, 2017
$
1,107


Schedule of changes in the components of accumulated other comprehensive loss
The following table summarizes the changes in the components of accumulated other comprehensive loss for the six months ended June 30, 2017:
(in millions)
Foreign Currency Translation Adjustment
 
Pension and Postretirement Benefit Plans
 
Unrealized Gain (Loss) on Forward Exchange Contracts
 
Accumulated Other Comprehensive Loss
Balance as of December 31, 2016
$
(332
)
 
$
(443
)
 
$
2

 
$
(773
)
Other comprehensive income before reclassifications
72

 
(1
)
 
1

 
72

Reclassifications from accumulated other comprehensive loss to net earnings

 
6

1 

(4
)
2 

2

Net other comprehensive income
72

 
5

 
(3
)
 
74

Balance as of June 30, 2017
$
(260
)
 
$
(438
)
 
$
(1
)
 
$
(699
)
1 
See Note 6 Employee Benefits for additional details of items reclassed from accumulated other comprehensive loss to net earnings.
2 
See Note 5 Derivative Instruments for additional details of items reclassed from accumulated other comprehensive loss to net earnings.